The pharmaceutical company Vivus announced today that its drug Qnexa aid weight loss met the criteria of efficiency required by the authority of American medicine, the Food and Drug Administration in two clinical trials . These studies constitute the last stage before the application for authorization to market that should be filed before the end of the year. The laboratory provides product launch in early 2011.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment